Santos et al. Mol Psychiatry. 2021


Deficient LEF1 expression is associated with lithium resistance and hyperexcitability in neurons derived from bipolar disorder patients. Santos R, Linker SB, Stern S, Mendes AP, Shokhirev MN, Erikson G, Randolph-Moore L, Racha V, Yeni K, Kelsoe JR, Bang AG, Alda M, Marchetto MC, Gage FH. Mol Psychiatry. 2021. https://doi.org/10.1038/s41380-020-00981-3. Download from HAL-INSERM

 

Bipolar disorder (BD) is a psychiatric condition characterized by depressive and manic episodes that affect 2% of the world population. The first-line long-term treatment for mood stabilization is lithium (Li). Induced pluripotent stem cell modeling of BD using hippocampal dentate gyrus-like neurons derived from Li-responsive (LR) and Li-non-responsive (NR) patients previously showed neuronal hyperexcitability. Li treatment reversed hyperexcitability only on the LR neurons. In this study we searched for specific targets of Li resistance in NR neurons and found that the activity of Wnt/β-catenin signaling pathway was severely affected, with a significant decrease in expression of LEF1. Li targets the Wnt/β-catenin signaling pathway by inhibiting GSK-3β and releasing β-catenin that forms a nuclear complex with TCF/LEF1, activating the Wnt/β-catenin transcription program. Therefore, we propose that downregulation of LEF1 may account for Li resistance in NR neurons. Our results show that valproic acid (VPA), a drug used to treat NR patients that also acts downstream of GSK-3β, upregulated LEF1 and Wnt/β-catenin gene targets, increased transcriptional activity of complex β-catenin/TCF/LEF1, and reduced excitability in NR neurons. In addition, decreasing LEF1 expression in control neurons using shLEF1 caused hyperexcitability, confirming that the impact of VPA on excitability in NR neurons was connected to changes in LEF1 and in the Wnt/β-catenin pathway. Our results suggest that LEF1 may be a useful target for the discovery of new drugs for BD treatment.

This part of the website could either be in French or English, depending on the sources of the actualities.

SIDEBAR_ARCHIVE_TITLE

 25 April 2023
Hemorrhagic Stroke: Current Research regarding Etiological Diagnosis
 01 March 2023 20 March 2023
Semaine du Cerveau 25ème édition
 01 March 2023 14 March 2023
Conférence inaugurale de la Semaine du Cerveau: Neurosciences et Psychiatrie, un vertueux mariage
 24 February 2023 18 March 2023
NeuroFrance 2023
 02 September 2022
The reciprocal interplay between nutrient sensing and secretory pathways defines cellular homeostasis
 01 July 2022
Cortical wiring by synapsespecific control of local protein synthesis
 20 June 2022
Demars et al. Curr Biol. 2022
 10 June 2022
A "Neurotour de France" - Ep. 2, présentation of IPNP
 03 June 2022
Programming neural cells for disease modelling and therapy development
 31 May 2022
Call for group leaders
 06 May 2022
Phenomenology and pathophysiology of antipsychotic-induced compulsive behaviour
 01 April 2022
Medial Septum cholinergic inputs to CA2: a new role in social novelty discrimination
 21 March 2022
Olié et al. Cereb Cortex. 2022
 04 March 2022
Molecular Dissection of Selective Neuronal Vulnerability in Alzheimer's Disease
 23 February 2022
Sánchez-Rico et al. J Travel Med. 2022
 04 February 2022
Quantitative analysis and modelling of dendrite growth
 20 January 2022
Hoertel et al. Biol Psychiatry Glob Open Sci. 2022
 07 January 2022
Neurobiology of social and non social decision-making processes in mouse models
 21 December 2021 31 December 2021
Psychiatry and Neuroscience Seminar Series 2021
 03 December 2021
Deconstructing the role of dopamine signaling in defensive behaviors